Although microRNAs were brought into the spotlight only recently, their role in regulating mammalian development and disease has become clear. miRNAs represent a novel class of targets for therapeutic and diagnostic development, currently not fully exploited by the pharmaceutical and biotechnology industries. Cambridge Healthtech Institute’s Fifth Annual microRNA in Human Disease and Development meeting is specifically designed to address the role of miRNA in human development and disease, and to explore the impact of this new research for drug and diagnostic development. The meeting will cover progress in identifying human miRNA, technologies used for miRNA profiling, and the latest research in linking miRNA to human disease. Opportunities for using miRNA as diagnostic biomarkers and a novel class of targets for therapeutic development will be explored.
Topics Include:
- miRNA identification and profiling approaches (microarrays, PCR, informatics, etc.)
- miRNA pathways and mechanisms
- miRNA role in development and disease, focusing on cancer
- miRNA biomarkers for diagnostic development
- miRNA targets for therapeutic development
- microRNA polymorphisms
Deadline for submission is Friday, August 29, 2008
Please click here to submit your proposal.
For more information, please contact:
Julia Boguslavsky, Executive Director, Conferences
E-mail: juliab@healthtech.com
For sponsorship information, please contact:
Carol Dinerstein, Business Development
Phone: 781-972-5471; E-mail: dinerstein@healthtech.com